Tiziana Life Sciences to Participate in a Fireside Chat at B. Riley Virtual Oncology Investor Conference on 21 January 2021 at 3 pm ET/8 pm GMT
20 janv. 2021 06h31 HE
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences plc ("Tiziana" or the "Company") - AIM Delisting and Admission to the Standard Listing Segment of Main Market
20 janv. 2021 02h00 HE
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics...
Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer
13 janv. 2021 02h00 HE
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences to participate at J.P. Morgan Healthcare Conference 2021
11 janv. 2021 12h08 HE
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences to Present at Biotech Showcase Digital 2021
11 janv. 2021 09h48 HE
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences plc ("Tiziana" or the "Company") - Tiziana announces completion of the clinical trial with nasally administered Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, for the treatment of COVID-19 patients in Brazil
04 janv. 2021 02h00 HE
|
Tiziana Life Sciences Plc
Anecdotal feedback from Foralumab-treated patients was positive and suggests that the treatment was well-toleratedThe scientific approaches underlying this clinical study could potentially be...
Tiziana Life Sciences PLC (“Tiziana” or “the Company”) - Publication of Prospectus
18 déc. 2020 06h38 HE
|
Tiziana Life Sciences Plc
This announcement is an advertisement and not a prospectus. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or...
Tiziana Life Sciences PLC (“Tiziana” or “the Company”) - Notification of proposed admission to the Main Market and cancellation of trading on AIM
17 déc. 2020 10h04 HE
|
Tiziana Life Sciences Plc
LONDON and NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences to Host Investor Update Call on 2 December 2020 at 4:15 p.m. ET
01 déc. 2020 02h00 HE
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology,...
Tiziana Life Sciences PLC ("Tiziana" or the "Company") - PDMR Dealing
18 nov. 2020 10h16 HE
|
Tiziana Life Sciences Plc
LONDON and NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...